Christin Yen-Ming Sander, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sensory Receptor Cells | 3 | 2020 | 492 | 1.380 |
Why?
|
| Positron-Emission Tomography | 12 | 2021 | 6234 | 1.350 |
Why?
|
| Receptors, Dopamine D3 | 3 | 2017 | 110 | 1.080 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2017 | 475 | 0.950 |
Why?
|
| Radiopharmaceuticals | 5 | 2021 | 2645 | 0.860 |
Why?
|
| Cerebrovascular Circulation | 4 | 2021 | 2731 | 0.810 |
Why?
|
| Proteins | 10 | 2024 | 6103 | 0.770 |
Why?
|
| Acetamides | 1 | 2021 | 249 | 0.690 |
Why?
|
| N-Methylaspartate | 1 | 2018 | 231 | 0.630 |
Why?
|
| Evolution, Molecular | 7 | 2023 | 1940 | 0.630 |
Why?
|
| Brain | 11 | 2023 | 26385 | 0.600 |
Why?
|
| Papio | 3 | 2017 | 656 | 0.590 |
Why?
|
| Rodentia | 1 | 2018 | 261 | 0.580 |
Why?
|
| Computational Biology | 5 | 2021 | 3521 | 0.560 |
Why?
|
| Sequence Analysis, Protein | 4 | 2015 | 258 | 0.560 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 298 | 0.550 |
Why?
|
| Quinpirole | 1 | 2015 | 33 | 0.540 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2203 | 0.480 |
Why?
|
| Proteomics | 3 | 2021 | 3638 | 0.470 |
Why?
|
| Raclopride | 3 | 2021 | 97 | 0.470 |
Why?
|
| Dopamine Agonists | 2 | 2015 | 355 | 0.460 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6489 | 0.460 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 35421 | 0.430 |
Why?
|
| Low Back Pain | 1 | 2021 | 956 | 0.430 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 895 | 0.420 |
Why?
|
| Protein Conformation | 7 | 2019 | 4011 | 0.420 |
Why?
|
| Brain Diseases | 1 | 2021 | 1563 | 0.410 |
Why?
|
| Phosphoproteins | 1 | 2020 | 2440 | 0.390 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 1178 | 0.380 |
Why?
|
| Models, Chemical | 1 | 2012 | 626 | 0.370 |
Why?
|
| Pyridines | 1 | 2021 | 2825 | 0.340 |
Why?
|
| Models, Molecular | 6 | 2016 | 5456 | 0.330 |
Why?
|
| Spin Labels | 2 | 2021 | 332 | 0.310 |
Why?
|
| Primates | 2 | 2021 | 545 | 0.300 |
Why?
|
| Macaca mulatta | 4 | 2017 | 2375 | 0.280 |
Why?
|
| Models, Neurological | 4 | 2016 | 1774 | 0.270 |
Why?
|
| Epistasis, Genetic | 2 | 2019 | 365 | 0.260 |
Why?
|
| Dopamine Antagonists | 3 | 2015 | 296 | 0.250 |
Why?
|
| Software | 6 | 2023 | 4443 | 0.250 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4838 | 0.250 |
Why?
|
| Protein Interaction Mapping | 2 | 2021 | 627 | 0.250 |
Why?
|
| Lanthanoid Series Elements | 1 | 2024 | 16 | 0.240 |
Why?
|
| Genetic Variation | 4 | 2017 | 6544 | 0.240 |
Why?
|
| Libraries | 1 | 2023 | 21 | 0.240 |
Why?
|
| Brain Mapping | 2 | 2016 | 6669 | 0.210 |
Why?
|
| Models, Genetic | 1 | 2012 | 3494 | 0.210 |
Why?
|
| Hypercapnia | 2 | 2021 | 260 | 0.200 |
Why?
|
| Melanoma | 1 | 2020 | 5510 | 0.200 |
Why?
|
| Immune Evasion | 1 | 2023 | 360 | 0.180 |
Why?
|
| Viruses | 1 | 2023 | 374 | 0.180 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2019 | 36 | 0.170 |
Why?
|
| Receptors, GABA | 1 | 2021 | 288 | 0.170 |
Why?
|
| RNA, Catalytic | 1 | 2019 | 50 | 0.170 |
Why?
|
| Glycolysis | 1 | 2023 | 827 | 0.170 |
Why?
|
| Animals | 20 | 2023 | 168757 | 0.170 |
Why?
|
| Neoplasms | 5 | 2023 | 21683 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2022 | 582 | 0.160 |
Why?
|
| Sequence Analysis | 1 | 2019 | 256 | 0.160 |
Why?
|
| Microbial Consortia | 1 | 2018 | 32 | 0.160 |
Why?
|
| Serotonin 5-HT1 Receptor Antagonists | 1 | 2017 | 9 | 0.160 |
Why?
|
| Drug Partial Agonism | 1 | 2017 | 24 | 0.160 |
Why?
|
| Dopamine | 2 | 2017 | 1591 | 0.160 |
Why?
|
| Phencyclidine | 1 | 2017 | 61 | 0.160 |
Why?
|
| Escherichia coli Proteins | 2 | 2015 | 1050 | 0.150 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 43 | 0.150 |
Why?
|
| Immunity | 1 | 2023 | 1012 | 0.150 |
Why?
|
| Dizocilpine Maleate | 1 | 2017 | 176 | 0.150 |
Why?
|
| Leucine | 1 | 2019 | 561 | 0.150 |
Why?
|
| Radionuclide Imaging | 1 | 2021 | 2031 | 0.150 |
Why?
|
| Protein Structure, Secondary | 3 | 2016 | 1246 | 0.150 |
Why?
|
| Protein Engineering | 1 | 2021 | 540 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13695 | 0.150 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 2025 | 0.150 |
Why?
|
| Perfusion | 1 | 2021 | 1360 | 0.140 |
Why?
|
| Systems Biology | 1 | 2020 | 469 | 0.140 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 675 | 0.140 |
Why?
|
| Binding, Competitive | 1 | 2017 | 1157 | 0.140 |
Why?
|
| Prochlorperazine | 1 | 2015 | 17 | 0.140 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2866 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2916 | 0.140 |
Why?
|
| Methamphetamine | 1 | 2017 | 154 | 0.140 |
Why?
|
| Mutation | 7 | 2023 | 29786 | 0.130 |
Why?
|
| Thermodynamics | 1 | 2017 | 596 | 0.130 |
Why?
|
| Conserved Sequence | 2 | 2017 | 1202 | 0.130 |
Why?
|
| Entropy | 2 | 2016 | 209 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2017 | 449 | 0.130 |
Why?
|
| Protein Folding | 2 | 2019 | 843 | 0.130 |
Why?
|
| Drug Design | 3 | 2023 | 1076 | 0.130 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 442 | 0.120 |
Why?
|
| Forecasting | 1 | 2023 | 2951 | 0.120 |
Why?
|
| Databases, Protein | 3 | 2021 | 383 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 2 | 2023 | 5256 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2024 | 13815 | 0.120 |
Why?
|
| Computer Simulation | 3 | 2018 | 6196 | 0.120 |
Why?
|
| Kinetics | 1 | 2021 | 6473 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1364 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2023 | 2183 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2020 | 1359 | 0.110 |
Why?
|
| Drug Interactions | 1 | 2017 | 1460 | 0.110 |
Why?
|
| Nucleic Acid Conformation | 1 | 2016 | 913 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2015 | 4217 | 0.110 |
Why?
|
| Monocytes | 1 | 2022 | 2596 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 453 | 0.110 |
Why?
|
| Humans | 29 | 2023 | 744343 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 403 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1634 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2021 | 4217 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1607 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2016 | 3846 | 0.100 |
Why?
|
| Benzamides | 1 | 2017 | 1379 | 0.100 |
Why?
|
| Ketamine | 1 | 2017 | 500 | 0.100 |
Why?
|
| Azepines | 1 | 2013 | 336 | 0.100 |
Why?
|
| Rhodopsin | 1 | 2011 | 203 | 0.100 |
Why?
|
| Trypsin | 1 | 2011 | 511 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 16689 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2187 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 19905 | 0.090 |
Why?
|
| Algorithms | 4 | 2021 | 13881 | 0.090 |
Why?
|
| Databases, Factual | 2 | 2021 | 7729 | 0.090 |
Why?
|
| Cell Survival | 1 | 2020 | 5882 | 0.090 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2010 | 63 | 0.090 |
Why?
|
| Basal Ganglia | 1 | 2013 | 546 | 0.090 |
Why?
|
| Proteome | 2 | 2017 | 1799 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2023 | 23403 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2019 | 1888 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 760 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2011 | 698 | 0.090 |
Why?
|
| Piperidines | 1 | 2017 | 1602 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1881 | 0.090 |
Why?
|
| Weight Loss | 1 | 2020 | 2622 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2013 | 1252 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2017 | 1901 | 0.080 |
Why?
|
| Cytokines | 1 | 2023 | 7322 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 4186 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2021 | 5021 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2017 | 4199 | 0.070 |
Why?
|
| Liposarcoma | 1 | 2010 | 333 | 0.070 |
Why?
|
| Indoles | 1 | 2015 | 1839 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1622 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.070 |
Why?
|
| Genome, Human | 1 | 2020 | 4420 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8301 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2017 | 18111 | 0.070 |
Why?
|
| Genome | 2 | 2011 | 1808 | 0.070 |
Why?
|
| Equipment Design | 1 | 2014 | 3582 | 0.070 |
Why?
|
| Male | 10 | 2023 | 350118 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 3848 | 0.070 |
Why?
|
| Visual Perception | 1 | 2014 | 1420 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2005 | 109 | 0.060 |
Why?
|
| Systems Integration | 1 | 2007 | 440 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 2988 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.060 |
Why?
|
| Antibodies | 2 | 2024 | 2460 | 0.060 |
Why?
|
| Nipah Virus | 1 | 2023 | 8 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2023 | 9438 | 0.060 |
Why?
|
| Models, Biological | 1 | 2020 | 9583 | 0.060 |
Why?
|
| Amino Acids | 2 | 2014 | 1736 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21746 | 0.060 |
Why?
|
| Pandemics | 1 | 2023 | 8388 | 0.060 |
Why?
|
| Lassa virus | 1 | 2023 | 97 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2023 | 249 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10638 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2022 | 70 | 0.050 |
Why?
|
| Biotechnology | 1 | 2024 | 281 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2214 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2019 | 2256 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2022 | 224 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 14722 | 0.050 |
Why?
|
| DNA Breaks | 1 | 2020 | 49 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2014 | 6256 | 0.040 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2019 | 12208 | 0.040 |
Why?
|
| R-SNARE Proteins | 1 | 2019 | 74 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2003 | 587 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1897 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 279 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2013 | 3143 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4042 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2017 | 33 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 972 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2023 | 636 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2021 | 497 | 0.040 |
Why?
|
| Female | 7 | 2023 | 380194 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2022 | 495 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 4262 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2011 | 5102 | 0.040 |
Why?
|
| Cell Communication | 1 | 2023 | 1621 | 0.030 |
Why?
|
| Data Mining | 1 | 2021 | 537 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2003 | 1041 | 0.030 |
Why?
|
| Directed Molecular Evolution | 1 | 2016 | 160 | 0.030 |
Why?
|
| Antigens | 1 | 2021 | 1466 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2007 | 2265 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7880 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 3703 | 0.030 |
Why?
|
| Research Design | 2 | 2007 | 5987 | 0.030 |
Why?
|
| Radiochemistry | 1 | 2013 | 55 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2046 | 0.030 |
Why?
|
| Mice | 5 | 2023 | 81183 | 0.030 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.030 |
Why?
|
| Genomics | 2 | 2021 | 5720 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 500 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 1783 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 91 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2023 | 1479 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3474 | 0.030 |
Why?
|
| Estrogens | 1 | 2019 | 1566 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20822 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 213383 | 0.020 |
Why?
|
| Glucose | 1 | 2023 | 4397 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 3309 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 377 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 2872 | 0.020 |
Why?
|
| Calcium | 1 | 2024 | 5756 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2005 | 3752 | 0.020 |
Why?
|
| RNA | 1 | 2019 | 2749 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 1534 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3064 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5524 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 1017 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1903 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12951 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1708 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1097 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 2016 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 12072 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9648 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5078 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8428 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1581 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16365 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10481 | 0.010 |
Why?
|
| Rats | 2 | 2013 | 24260 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12720 | 0.010 |
Why?
|
| Database Management Systems | 1 | 2003 | 270 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12797 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9386 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 39050 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 12261 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 2008 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1791 | 0.010 |
Why?
|
| Research | 1 | 2007 | 1999 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 824 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
| HIV Infections | 1 | 2023 | 16718 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2003 | 3588 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3920 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1547 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 3617 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 163280 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 13033 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 15519 | 0.000 |
Why?
|